Gunther Birznieks
2017
In 2017, Gunther Birznieks earned a total compensation of $1.8M as Senior Vice President, Business Development at Vanda Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $195,000 |
|---|---|
| Option Awards | $728,203 |
| Salary | $325,000 |
| Stock Awards | $565,500 |
| Other | $14,992 |
| Total | $1,828,695 |
Birznieks received $728.2K in option awards, accounting for 40% of the total pay in 2017.
Birznieks also received $195K in non-equity incentive plan, $325K in salary, $565.5K in stock awards and $15K in other compensation.
Rankings
In 2017, Gunther Birznieks' compensation ranked 5,938th out of 14,666 executives tracked by ExecPay. In other words, Birznieks earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,938 out of 14,666 | 60th |
Division Manufacturing | 2,169 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 677 out of 2,075 | 67th |
Industry group Drugs | 524 out of 1,731 | 70th |
Industry Pharmaceutical Preparations | 416 out of 1,333 | 69th |
Source: SEC filing on April 27, 2018.
Birznieks' colleagues
We found four more compensation records of executives who worked with Gunther Birznieks at Vanda Pharmaceuticals in 2017.